Alterations at the FRA3B CFS, centered within the FHIT gene locus, leads to partial or full loss of FHIT gene and protein expression in >50% of sporadic cancers [26–29], many of which exhibit APOBEC signature mutations [6, 14]. Here, FHIT is linked to cancer.